#news #biotech FDA hits Advaxis with clinical hold after death in AstraZeneca combination trial

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FDA hits Advaxis with clinical hold after death in AstraZeneca combination trial .The FDA has placed a clinical hold on a study of Advaxis’ axalimogene filolisbac and AstraZeneca’s PD-L1 checkpoint inhibitor Imfinzi. Regulatory officials took the action upon learning a cervical cancer patient developed respiratory failure and died after receiving the combination.

from FierceBiotech: Biotech http://ift.tt/2FS7FgG